Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-16
Pages: 126 Pages
Report ld: 2686949
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2024-2030
-2.8%
Market Size,2030
USD 2
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 3 million
Market Forecast in 2030(Value)
US$ 2 million
CAGR
-2.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The global Octreotide market is projected to reach US$ 2 million by 2030 from an estimated US$ 3 million in 2024, at a CAGR of -2.8% during 2024 and 2030.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
MARKET SEGMENTATION
By Company
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Segment by Application
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Octreotide.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Octreotide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Octreotide Product Introduction
1.2 Market by Type
1.2.1 Global Octreotide Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market by Application
1.3.1 Global Octreotide Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Octreotide Market Size Estimates and Forecasts
2.1.1 Global Octreotide Revenue 2019-2030
2.1.2 Global Octreotide Sales 2019-2030
2.2 Octreotide Market Size by Region: 2023 Versus 2030
2.3 Octreotide Sales by Region (2019-2030)
2.3.1 Global Octreotide Sales by Region: 2019-2024
2.3.2 Global Octreotide Sales Forecast by Region (2025-2030)
2.3.3 Global Octreotide Sales Market Share by Region (2019-2030)
2.4 Octreotide Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Octreotide Revenue by Region: 2019-2024
2.4.2 Global Octreotide Revenue Forecast by Region (2025-2030)
2.4.3 Global Octreotide Revenue Market Share by Region (2019-2030)
3 Global Octreotide by Manufacturers
3.1 Global Top Octreotide Manufacturers by Sales
3.1.1 Global Octreotide Sales by Manufacturer (2019-2024)
3.1.2 Global Octreotide Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Octreotide Manufacturers by Revenue
3.2.1 Global Octreotide Revenue by Manufacturer (2019-2024)
3.2.2 Global Octreotide Revenue Share by Manufacturer (2019-2024)
3.3 Global Octreotide Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Octreotide Manufacturers Covered: Ranking by Revenue
3.4.2 Global Octreotide Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Octreotide Manufacturing Base Distribution, Product Type
3.5.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Octreotide Product Type
3.5.3 Date of International Manufacturers Enter into Octreotide Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novartis
4.1.1 Novartis Company Information
4.1.2 Novartis Description, Business Overview
4.1.3 Novartis Octreotide Products Offered
4.1.4 Novartis Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Novartis Octreotide Sales by Product in 2023
4.1.6 Novartis Octreotide Sales by Application in 2023
4.1.7 Novartis Octreotide Sales by Geographic Area in 2023
4.1.8 Novartis Recent Developments
4.2 Sun Pharmaceutical
4.2.1 Sun Pharmaceutical Company Information
4.2.2 Sun Pharmaceutical Description, Business Overview
4.2.3 Sun Pharmaceutical Octreotide Products Offered
4.2.4 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Sun Pharmaceutical Octreotide Sales by Product in 2023
4.2.6 Sun Pharmaceutical Octreotide Sales by Application in 2023
4.2.7 Sun Pharmaceutical Octreotide Sales by Geographic Area in 2023
4.2.8 Sun Pharmaceutical Recent Developments
4.3 Chengdu Tiantaishan pharmaceutical
4.3.1 Chengdu Tiantaishan pharmaceutical Company Information
4.3.2 Chengdu Tiantaishan pharmaceutical Description, Business Overview
4.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
4.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Product in 2023
4.3.6 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Application in 2023
4.3.7 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Geographic Area in 2023
4.3.8 Chengdu Tiantaishan pharmaceutical Recent Developments
4.4 Sinopharm A-Think Pharmaceuticals
4.4.1 Sinopharm A-Think Pharmaceuticals Company Information
4.4.2 Sinopharm A-Think Pharmaceuticals Description, Business Overview
4.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
4.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Product in 2023
4.4.6 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Application in 2023
4.4.7 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Geographic Area in 2023
4.4.8 Sinopharm A-Think Pharmaceuticals Recent Developments
4.5 Sihuan Pharmaceutical Holdings Group
4.5.1 Sihuan Pharmaceutical Holdings Group Company Information
4.5.2 Sihuan Pharmaceutical Holdings Group Description, Business Overview
4.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
4.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Product in 2023
4.5.6 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Application in 2023
4.5.7 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Geographic Area in 2023
4.5.8 Sihuan Pharmaceutical Holdings Group Recent Developments
4.6 Shanghai Soho-Yiming Pharmaceuticals
4.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
4.6.2 Shanghai Soho-Yiming Pharmaceuticals Description, Business Overview
4.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
4.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Product in 2023
4.6.6 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Application in 2023
4.6.7 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Geographic Area in 2023
4.6.8 Shanghai Soho-Yiming Pharmaceuticals Recent Development
4.7 Yibin Pharmaceutical
4.7.1 Yibin Pharmaceutical Company Information
4.7.2 Yibin Pharmaceutical Description, Business Overview
4.7.3 Yibin Pharmaceutical Octreotide Products Offered
4.7.4 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Yibin Pharmaceutical Octreotide Sales by Product in 2023
4.7.6 Yibin Pharmaceutical Octreotide Sales by Application in 2023
4.7.7 Yibin Pharmaceutical Octreotide Sales by Geographic Area in 2023
4.7.8 Yibin Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Octreotide Sales by Type (2019-2030)
5.1.1 Global Octreotide Sales by Type (2019-2024)
5.1.2 Global Octreotide Sales Forecast by Type (2025-2030)
5.1.3 Global Octreotide Sales Market Share by Type (2019-2030)
5.2 Global Octreotide Revenue Forecast by Type (2019-2030)
5.2.1 Global Octreotide Revenue by Type (2019-2024)
5.2.2 Global Octreotide Revenue Forecast by Type (2025-2030)
5.2.3 Global Octreotide Revenue Market Share by Type (2019-2030)
5.3 Octreotide Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Octreotide Sales by Application (2019-2030)
6.1.1 Global Octreotide Sales by Application (2019-2024)
6.1.2 Global Octreotide Sales Forecast by Application (2025-2030)
6.1.3 Global Octreotide Sales Market Share by Application (2019-2030)
6.2 Global Octreotide Revenue Forecast by Application (2019-2030)
6.2.1 Global Octreotide Revenue by Application (2019-2024)
6.2.2 Global Octreotide Revenue Forecast by Application (2025-2030)
6.2.3 Global Octreotide Revenue Market Share by Application (2019-2030)
6.3 Octreotide Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Octreotide Market Size YoY Growth 2019-2030
7.2 North America Octreotide Market Facts & Figures by Country
7.2.1 North America Octreotide Sales by Country (2019-2030)
7.2.2 North America Octreotide Revenue by Country (2019-2030)
7.3 North America Octreotide Sales by Type (2019-2024)
7.4 North America Octreotide Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Octreotide Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Octreotide Market Facts & Figures by Region
8.2.1 Asia-Pacific Octreotide Sales by Region (2019-2030)
8.2.2 Asia-Pacific Octreotide Revenue by Region (2019-2030)
8.3 Asia-Pacific Octreotide Sales by Type (2019-2024)
8.4 Asia-Pacific Octreotide Sales by Application (2019-2024)
9 Europe
9.1 Europe Octreotide Market Size YoY Growth 2019-2030
9.2 Europe Octreotide Market Facts & Figures by Country
9.2.1 Europe Octreotide Sales by Country (2019-2030)
9.2.2 Europe Octreotide Revenue by Country (2019-2030)
9.3 Europe Octreotide Sales by Type (2019-2024)
9.4 Europe Octreotide Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Octreotide Market Size YoY Growth 2019-2030
10.2 Latin America Octreotide Market Facts & Figures by Country
10.2.1 Latin America Octreotide Sales by Country (2019-2030)
10.2.2 Latin America Octreotide Revenue by Country (2019-2030)
10.3 Latin America Octreotide Sales by Type (2019-2024)
10.4 Latin America Octreotide Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Octreotide Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Octreotide Market Facts & Figures by Country
11.2.1 Middle East and Africa Octreotide Sales by Country (2019-2030)
11.2.2 Middle East and Africa Octreotide Revenue by Country (2019-2030)
11.3 Middle East and Africa Octreotide Sales by Type (2019-2024)
11.4 Middle East and Africa Octreotide Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Octreotide Supply Chain Analysis
12.2 Octreotide Key Raw Materials and Upstream Suppliers
12.3 Octreotide Clients Analysis
12.4 Octreotide Sales Channel and Sales Model Analysis
12.4.1 Octreotide Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Octreotide Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Octreotide Distributors
13 Market Dynamics
13.1 Octreotide Industry Trends
13.2 Octreotide Market Drivers
13.3 Octreotide Market Challenges
13.4 Octreotide Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Octreotide Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Manufacturers of Octreotide Injection
Table 3. Major Manufacturers of Octreotide Powder
Table 4. Major Manufacturers of Octreotide Microspheres
Table 5. Global Octreotide Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Octreotide Market Size by Region (US$ Million): 2023 VS 2030
Table 7. Global Octreotide Sales by Region (2019-2024) & (Gram)
Table 8. Global Octreotide Sales Forecast by Region (2025-2030) & (Gram)
Table 9. Global Octreotide Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Octreotide Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 11. Global Octreotide Sales by Manufacturer (2019-2024) & (Gram)
Table 12. Global Octreotide Sales Share by Manufacturer (2019-2024)
Table 13. Octreotide Revenue by Manufacturer (2019-2024) & (US$ Million)
Table 14. Octreotide Revenue Share by Manufacturer (2019-2024)
Table 15. Key Manufacturers Octreotide Price (2019-2024) & (USD/Gram)
Table 16. Ranking of Global Top Octreotide Manufacturers by Revenue (US$ Million) in 2023
Table 17. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 18. Global Octreotide by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Octreotide as of 2023)
Table 19. Octreotide Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Octreotide Product Type
Table 21. Date of International Manufacturers Enter into Octreotide Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Novartis Company Information
Table 24. Novartis Description and Business Overview
Table 25. Novartis Octreotide Product
Table 26. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 27. Novartis Sales Proportion of Octreotide by Product in 2023
Table 28. Novartis Sales Proportion of Octreotide by Application in 2023
Table 29. Novartis Sales Proportion of Octreotide by Geographic Area in 2023
Table 30. Novartis Recent Development
Table 31. Sun Pharmaceutical Company Information
Table 32. Sun Pharmaceutical Description and Business Overview
Table 33. Sun Pharmaceutical Octreotide Product
Table 34. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 35. Sun Pharmaceutical Sales Proportion of Octreotide by Product in 2023
Table 36. Sun Pharmaceutical Sales Proportion of Octreotide by Application in 2023
Table 37. Sun Pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2023
Table 38. Sun Pharmaceutical Recent Development
Table 39. Chengdu Tiantaishan pharmaceutical Company Information
Table 40. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 41. Chengdu Tiantaishan pharmaceutical Octreotide Product
Table 42. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 43. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Product in 2023
Table 44. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Application in 2023
Table 45. Chengdu Tiantaishan pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2023
Table 46. Chengdu Tiantaishan pharmaceutical Recent Development
Table 47. Sinopharm A-Think Pharmaceuticals Company Information
Table 48. Sinopharm A-Think Pharmaceuticals Description and Business Overview
Table 49. Sinopharm A-Think Pharmaceuticals Octreotide Product
Table 50. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 51. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Product in 2023
Table 52. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Application in 2023
Table 53. Sinopharm A-Think Pharmaceuticals Sales Proportion of Octreotide by Geographic Area in 2023
Table 54. Sinopharm A-Think Pharmaceuticals Recent Development
Table 55. Sihuan Pharmaceutical Holdings Group Company Information
Table 56. Sihuan Pharmaceutical Holdings Group Description and Business Overview
Table 57. Sihuan Pharmaceutical Holdings Group Octreotide Product
Table 58. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 59. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Product in 2023
Table 60. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Application in 2023
Table 61. Sihuan Pharmaceutical Holdings Group Sales Proportion of Octreotide by Geographic Area in 2023
Table 62. Sihuan Pharmaceutical Holdings Group Recent Development
Table 63. Shanghai Soho-Yiming Pharmaceuticals Company Information
Table 64. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 65. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product
Table 66. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 67. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Product in 2023
Table 68. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Application in 2023
Table 69. Shanghai Soho-Yiming Pharmaceuticals Sales Proportion of Octreotide by Geographic Area in 2023
Table 70. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 71. Yibin Pharmaceutical Company Information
Table 72. Yibin Pharmaceutical Description and Business Overview
Table 73. Yibin Pharmaceutical Octreotide Product
Table 74. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 75. Yibin Pharmaceutical Sales Proportion of Octreotide by Product in 2023
Table 76. Yibin Pharmaceutical Sales Proportion of Octreotide by Application in 2023
Table 77. Yibin Pharmaceutical Sales Proportion of Octreotide by Geographic Area in 2023
Table 78. Yibin Pharmaceutical Recent Development
Table 79. Global Octreotide Sales by Type (2019-2024) & (Gram)
Table 80. Global Octreotide Sales Forecast by Type (2025-2030) & (Gram)
Table 81. Global Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 82. Global Octreotide Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 83. Global Octreotide Sales by Application (2019-2024) & (Gram)
Table 84. Global Octreotide Sales Forecast by Application (2025-2030) & (Gram)
Table 85. Global Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 86. Global Octreotide Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 87. North America Octreotide Sales by Country (2019-2024) & (Gram)
Table 88. North America Octreotide Sales by Country (2025-2030) & (Gram)
Table 89. North America Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 90. North America Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 91. North America Octreotide Sales by Type (2019-2024) & (Gram)
Table 92. North America Octreotide Sales by Application (2019-2024) & (Gram)
Table 93. Asia-Pacific Octreotide Sales by Region (2019-2024) & (Gram)
Table 94. Asia-Pacific Octreotide Sales by Region (2025-2030) & (Gram)
Table 95. Asia-Pacific Octreotide Revenue by Region (2019-2030) & (US$ Million)
Table 96. Asia-Pacific Octreotide Revenue by Region (2025-2030) & (US$ Million)
Table 97. Asia-Pacific Octreotide Sales by Type (2019-2024) & (Gram)
Table 98. Asia-Pacific Octreotide Sales by Application (2019-2024) & (Gram)
Table 99. Europe Octreotide Sales by Country (2019-2024) & (Gram)
Table 100. Europe Octreotide Sales by Country (2025-2030) & (Gram)
Table 101. Europe Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 102. Europe Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 103. Europe Octreotide Sales by Type (2019-2024) & (Gram)
Table 104. Europe Octreotide Sales by Application (2019-2024) & (Gram)
Table 105. Latin America Octreotide Sales by Country (2019-2024) & (Gram)
Table 106. Latin America Octreotide Sales by Country (2025-2030) & (Gram)
Table 107. Latin America Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 108. Latin America Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 109. Latin America Octreotide Sales by Type (2019-2024) & (Gram)
Table 110. Latin America Octreotide Sales by Application (2019-2024) & (Gram)
Table 111. Middle East and Africa Octreotide Sales by Country (2019-2024) & (Gram)
Table 112. Middle East and Africa Octreotide Sales by Country (2025-2030) & (Gram)
Table 113. Middle East and Africa Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 114. Middle East and Africa Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 115. Middle East and Africa Octreotide Sales by Type (2019-2024) & (Gram)
Table 116. Middle East and Africa Octreotide Sales by Application (2019-2024) & (Gram)
Table 117. Octreotide Key Raw Materials, Industry Status and Trend
Table 118. Octreotide Key Raw Materials and Upstream Suppliers
Table 119. Octreotide Clients Status and Trend
Table 120. Octreotide Typical Clients
Table 121. Octreotide Distributors
Table 122. Octreotide Market Trends
Table 123. Octreotide Market Drivers
Table 124. Octreotide Market Challenges
Table 125. Octreotide Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Sales Market Share by Type in 2023 & 2030
Figure 3. Octreotide Injection Product Picture
Figure 4. Octreotide Powder Product Picture
Figure 5. Octreotide Microspheres Product Picture
Figure 6. Global Octreotide Sales Market Share by Application in 2023 & 2030
Figure 7. Treating Severe Diarrhea Examples
Figure 8. Treating Acromegaly Examples
Figure 9. Others Examples
Figure 10. Octreotide Report Years Considered
Figure 11. Global Octreotide Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Octreotide Market Size 2019-2030 (US$ Million)
Figure 13. Global Octreotide Sales 2019-2030 (Gram)
Figure 14. Global Octreotide Sales Market Share Forecast by Region (2019-2030)
Figure 15. Global Octreotide Revenue Market Share by Region (2019-2030)
Figure 16. Global Octreotide Sales Share by Manufacturer in 2023
Figure 17. Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 18. Global Octreotide Sales Market Share Forecast by Type (2019-2030)
Figure 19. Global Octreotide Revenue Market Share Forecast by Type (2019-2030)
Figure 20. Octreotide Average Selling Price (ASP) by Type (2019-2024) & (USD/Gram)
Figure 21. Global Octreotide Sales Market Share Forecast by Application (2019-2030)
Figure 22. Global Octreotide Revenue Market Share Forecast by Application (2019-2030)
Figure 23. Octreotide Average Selling Price (ASP) by Application (2019-2024) & (USD/Gram)
Figure 24. North America Octreotide Revenue 2019-2030 (US$ Million)
Figure 25. North America Octreotide Sales Market Share by Type (2019-2024)
Figure 26. North America Octreotide Sales Market Share by Application (2019-2024)
Figure 27. Asia-Pacific Octreotide Revenue 2019-2030 (US$ Million)
Figure 28. Asia-Pacific Octreotide Sales Market Share by Region (2019-2030)
Figure 29. Asia-Pacific Octreotide Revenue Market Share by Region (2019-2030)
Figure 30. Asia-Pacific Octreotide Sales Market Share by Type (2019-2024)
Figure 31. Asia-Pacific Octreotide Sales Market Share by Application (2019-2024)
Figure 32. Europe Octreotide Revenue Growth Rate 2019-2030 (US$ Million)
Figure 33. Europe Octreotide Sales Market Share by Country (2019-2030)
Figure 34. Europe Octreotide Revenue Market Share by Country (2019-2030)
Figure 35. Europe Octreotide Sales Market Share by Type (2019-2024)
Figure 36. Europe Octreotide Sales Market Share by Application (2019-2024)
Figure 37. Latin America Octreotide Revenue Growth Rate 2019-2030 (US$ Million)
Figure 38. Latin America Octreotide Sales Market Share by Country (2019-2030)
Figure 39. Latin America Octreotide Revenue Market Share by Country (2019-2024)
Figure 40. Latin America Octreotide Sales Market Share by Type (2019-2024)
Figure 41. Latin America Octreotide Sales Market Share by Application (2019-2024)
Figure 42. Middle East and Africa Octreotide Revenue Growth Rate 2019-2030 (US$ Million)
Figure 43. Middle East and Africa Octreotide Sales Market Share by Country (2019-2030)
Figure 44. Middle East and Africa Octreotide Revenue Market Share by Country (2019-2030)
Figure 45. Middle East and Africa Octreotide Sales Market Share by Type (2019-2024)
Figure 46. Middle East and Africa Octreotide Sales Market Share by Application (2019-2024)
Figure 47. Octreotide Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Octreotide Raw Materials by Region in 2023
Figure 49. Octreotide Distribution Channels
Figure 50. Global Octreotide Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 51. Global Octreotide Percentage 2019-2030: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Octreotide market size from 2024 to 2030?
The annual compound growth rate of the global Octreotide market is -2.8% 2024 to 2030.
Which companies rank high in the global Octreotide market?
Which region is expected to have the highest market share?
What was the global market size of Octreotide in 2024?
What was the global market size of Octreotide in 2030?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now